A panel of monoclonal antibodies has been produced against a 1983 human influenza A (H1N1) virus that has been isolated and grown exclusively in MDCK cells. Several of these antibodies were used to select variants from MDCK-derived virus in cells and their epitopes were then located by determining the HA1 amino acid sequence. The operational antigenic map of the haemagglutinin indicates the presence of two distinct immunodominant antigenic regions which correspond but are not identical to antigenic sites Sa and Sb of the A (H1N1) virus A/PR/8/34. Also during this study, we characterized a unique group of antibodies for which variants require two distinct and specific HA1 amino acid substitutions to escape neutralization.
Introduction
The haemagglutinin (HA) of influenza virus is the major viral target for immune mechanisms in addition to its role of mediating adsorption and penetration into host cells. The antigenic structure of the HAs of A (H1), A (H3) and B subtypes of influenza virus has been investigated by constructing operational antigenic maps and by amino acid sequence analysis of natural field isolates and laboratory-derived variants (Wiley et al., 1981 ; Gerhard et al., 1981 ; Caton et al., 1982; Hovanec & Air, 1984; Berton & Webster, 1985; Raymond et al., 1986) .
The antigenic map of an influenza A (H1NI) virus, A/PR/8/34 (PR8), indicates five immunodominant antigenic sites designated Sa, Sb, Ca1, Ca: and Cb (Gerhard et al., 1981 ; Caton et al., 1982) and is comparable to that for A (H3N2) viruses (Wiley et al., 1981) . However the PR8 virus analysed was isolated over 50 years ago and undoubtedly has undergone considerable laboratory adaptation and passage especially in the embryonated hen's egg. It has been demonstrated that during egg adaptation antigenic variants of influenza virus are selected (Schild et al., 1983; Oxford et al., 1987) , and specific changes in the HA of B, A (H1N1) and A (H3N2) viruses associated with egg adaptation have been characterized (Robertson et aL, 1985 Katz et al., 1987; Katz & Webster, 1988) .
The aim of this study was to investigate the antigenic structure of a human A (H 1N 1) influenza virus, isolated almost 50 years after the PR8 virus, and which has been isolated and undergone limited passage exclusively in mammalian tissue culture cells (MDCK). An operational antigenic map was constructed and the amino acid substitutions involved in antigenicity have been determined. We also determined that for variants to escape neutralization by a unique group of monoclonal antibodies (MAbs), two simultaneous amino acid substitutions on the HA1 are required either at positions 187 and 225 or at 189 and 225.
Methods
Viruses. The original viruses used in this study were obtained during an outbreak of influenza at Christ's Hospital Boarding School, Horsham, U.K. in February 1983 . Viruses were isolated and propagated in MDCK cells or in the allantoic cavity of 11 day old embryonated hens' eggs. The viruses were collected from culture medium or allantoic fluid by centrifugation and purified on sucrose density gradients (Skehel & Schild, 1971) .
MAbs. BALB/c mice were immunized intraperitoneally with approximately 20000 haemagglutinating units (HAU) of a purified virus, A/Chr/91/83, isolated and grown exclusively in MDCK cells, followed by booster doses at 6 and 8 weeks. Spleens were removed 3 days after the final immunization and fused with NSO myeloma cells using standard techniques (Gerhard, 1980) . The hybridoma cell supernates were screened for anti-influenza virus antibody production by ELISA in which plates were sensitized with 256 HAU of whole virus per well. Positive samples were cloned in soft agar and grown as ascites in BALB/c mice. Ascitic fluids were analysed for anti-HA antibodies by the haemagglutination inhibition (HI) assay. All antibodies with no HI activity were subsequently assigned to other viral polypeptides, primarily the nucleoprotein.
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Selection of antigenic variants. Anti-HA antibodies were used to select antigenic variants from virus A/Chr/157/83. MDCK-derived viruses A/Chr/157/83 and A/Chr/91/83, obtained from the same outbreak of influenza, cannot be distinguished antigenically and have identical HA gene nucleotide sequences (data not shown). For selection of variants on MDCK cells viruses were treated with doubling dilutions ofa MAb and incubated at room temperature for 1 h . The antibody virus mixtures were inoculated onto MDCK cells and grown in the presence of the selecting MAb at the same concentration to that used at the adsorption stage. Viruses obtained from cultures containing the minimum dilution of antibody at which virus escaped neutralization were cloned using a plaquing technique (Appleyard & Maber, 1974) .
Selection of antigenic variants was also carried out in the aUantoic cavity of 11 day old embryonated hens" eggs . The allantoic fluid was harvested at 3 days post-inoculation and the procedure repeated at a limiting dilution of virus so that a cloned population of virus was obtained.
Antigenic analysis. Haemagglutination titrations and HI tests were carried out using microtitre plates, employing 0.7% turkey red blood cells. Ascitic fluids were treated prior to assay with receptor-destroying enzyme.
RNA sequencing. Purified virus was disrupted in 10 mM-Tris-HCl pH 7.5, 5 mM-EDTA containing 0-5% SDS and treated with 50 p.g/ml proteinase K (BDH) for 30 rain at 37 °C. Total virion RNA was extracted twice with phenol-chloroform, twice with chloroform and then ethanol-precipitated. Nucleotide sequences were analysed directly by the dideoxynucleotide chain determination technique as described by Caton et al. (1982) using synthetic oligonucleotide primers supplied by A. Caton and R.S. Daniels.
Results

Selection and characterization of MDCK-derived antigenic variants
Thirty-six anti-haemagglutinin MAbs derived from four individual fusions were prepared using virus isolated and propagated exclusively on MDCK cells. They were grouped initially according to their HI reactivity with a series of human influenza A (H1NI) viruses obtained from previous epidemics (data not shown) and, using 13 representative antibodies, 26 antigenic variants were selected from a virus which was isolated on MDCK cells and has undergone limited laboratory passage on the same cell substrate. This virus, A/Chr/157/83, is designated 157M. Not all of the antibodies used gave rise to variants and resistant variants could not be selected on MDCK cells against antibodies 336 and 485.
An operational antigenic map of the 157M virus HA was constructed by testing each variant against the 36 MAbs in HI assays (Table 1) . Thirteen distinct antibody profiles were obtained including a profile exhibited by eight antibodies (Table 1 , group C) which had unchanged HI reactivity with all variants. There were 10 unique antigenic phenotypes amongst the 26 variants analysed and variants identical to M/725/V3A were isolated with high frequency and had lost HI reactivity with the greatest number of antibodies. The table shows two distinct, non-overlapping groups of virus-antibody interactions indicating at least two immunodominant antigenic regions on the HA of 157M virus.
The nucleotide sequence of the HAl-coding region of the unique antigenic variants was determined by the dideoxynucleotide chain termination procedure using synthetic oligonucleotide primers. For seven of the variants a single base substitution in the HAl-coding region was detected, each of which resulted in an altered amino acid residue ( Table 2) [for ease of comparison with the established three-dimensional (3D) structure of an H3 subtype haemagglutinin, H3 numbering is used throughout]. The remainder had two base changes which resulted in a single amino acid substitution in one variant and a double amino acid substitution in two variants. Several variants, antigenically identical to those whose substitutions are described in Table 2 , were sequenced and had identical amino acid substitutions (data not shown). Variants resistant to antibodies in reactivity group A arose with amino acid substitutions at residues 30, 82, 159, 163,167 and 171 (Table 2) . Variants resistant to antibodies in group B had substitutions at residues 102, 133, 188, 189 and 192 ( Table 2 ). The location of these substitutions on the 3D structure of H3 subtype HA is shown in Fig. 1 . The substitution at residue 163 (variant M/578/V21C), resulted in the loss of a glycosylation site.
Selection and characterization of antigenic var&nts resistant to antibody 485
No variants resistant to eight of the MAbs (Table 1 , group C) were obtained on MDCK cells. Two of these antibodies, 485 and 550, were used unsuccessfully on three occasions to select variants on MDCK cells. In an attempt to produce variants resistant to these antibodies, the selection process was performed in embryonated hens' eggs with virus 157E. This virus was isolated from the same clinical specimen as 157M, but in eggs instead of in tissue culture; 157E differs antigenically from 157M and structurally at HA l residues 163 and 189 . Virus 157E did not react in an HI test with most of the antibodies but retained high HI reactivity with the eight antibodies of group C (data not shown). Using antibody 485, antigenic variants were selected both in eggs and on MDCK cells from virus 157E (variants E/485/E2 and E/485/M2, Table 3 ). Subsequently variants resistant to antibody 485 were obtained from 157M virus in eggs (variant M/485/E3, Table 3 ). These three variants had lost HI reactivity with all group C antibodies (data not shown).
The HAl-coding regions of the antigenic variants M373  M373  M578  M339  M339  M740  M740  M725  M725  M721  Reactivity  V 1A  V2A  V21C  V1A  V6A  V3A  V2A  V3A  V4D  V6A  group MAb
-_+ 580 + 491 C 485 (7) * Of the 26 antigenic variants derived directly on MDCK cells from 157M virus, there were 10 unique antigenic phenotypes. Numbers in parentheses indicate the total number of antigenic variants with a particular antigenic phenotype.
t H3 subtype resistant to antibody 485 were subjected to sequence analysis and the deduced amino acid substitutions are shown in Table 3 . Each of the three variants had common substitutions at residues 225 (D~G) and 189 (E--,K) compared to 157M. These data suggested that, with certain MAbs viz. MAb 485, variants may require at least two amino acid substitutions, one at residue 225 and another at residue 189, to escape neutralization.
Selection of antigenic variants from previously character&ed egg-adapted variants
In a separate study shown). Significantly, egg-adapted variant 56c which had a double mutation at residues 187 and 225 had no HI reactivity with antibody 485 (Table 4) .
To test the premise that in order to lose HI reactivity with the group C antibodies, two substitutions are required (one at residue 225 and one in the region of residue 189), egg-adapted variants 5a, 5b and 21b were subjected to selection with antibody 485 on MDCK cells. The resulting variants had lost HI activity with antibody 485 (Table 4 ) and all other group C antibodies. The variants derived from 5a (189, E~K) and 5b (187, N~K) (Table 4 ). The full antigenic profiles of egg-adapted variant 56c and the variants selected by antibody 485 from 5b and 21b were identical (data not shown).
Discussion
The HA of the 1983 MDCK-derived influenza A (H1N1) virus A/Chr/157/83 contains at least two immunodominant antigenic regions (Table 1) which correspond approximately to antigenic sites Sa and Sb defined for A/PR/8/34 (PR8) (Caton et al., 1982) . PR8 was isolated almost 50 years previously and is antigenically distinct from 157M due to the evolution of H1N1 viruses since 1934, and presumably also to extensive laboratory passaging of PR8. In PR8, HA sites Sa and Sb are closely linked but separated by a polypeptide loop formed by residues 156 to 160. Site Sb is defined by residues 156 and 159 within this loop and by adjacent residues in a region of the a-helix at the top of the HA molecule. Site Sa is defined by the continuation of the polypeptide loop down the side of the HA molecule including most of the residues from 158 to 167. Site Sb of 157M comprises residues 133, 187, 188, 189 and 192 , the latter four of which are located in the short a-helix situated on the distal tip of the HA molecule (Fig.  l) . Site Sa of 157M is defined by residues 82, 159, 163, 167 and 171 (Fig. l) . Additional non-unique substitutions were found at residues 30, 102, 236 and 300. Residues 30 and 300 are located in the stem region and are unlikely to affect antigenicity whereas any contribution to antigenicity by residues 102 and 236, which occurred in variants M/740/V2A and E/485/M2 respectively, is unknown. Thus in 157M, site Sa covers a greater area and is not as closely linked to site Sb as in PR8. This is probably due to carbohydrate masking of site Sa. PR8 (Mt Sinai) used in the study by Caton et al. (1982) contains one glycosylation site in the HA1 globular head at Asn (271). In contrast recent H 1 N 1 viruses including 157M have four additional HA1 glycosylation sites at Asn residues 94a, 131, 158 and 163 (Raymond et al., 1986) . Glycosylation of residues 131,158 and 163 would considerably mask site Sa and form a barrier between this and site Sb resulting in their increased separation. The activity of some of the group A antibodies, viz. 377, 379 and 578, is potentially influenced by a carbohydrate at AsH (163), and the increased glycosylation of site Sa may also account for the large spread of epitopes within this region.
Most of the antibodies raised in this study were against site Sb and residue 225 in site Ca. Similarly, the location of substituted residues in field isolates in the study by Raymond et al. (1986) suggested that sites Sb and Ca are of greatest significance. The absence of immunodominant regions in 157M corresponding to PR8 sites Ca1, Ca 2 and Cb may also be due to the use of whole virus in this study to raise and characterize anti-HA antibodies whereas in Caton et al. (1982) several antibodies were raised against infected cells and all were characterized using disrupted virus.
To escape neutralization by the group C antibodies there was an absolute requirement for variants to substitute two specific amino acid residues. These could be either residues 187 and 225 or 189 and 225. In this study variants resistant to antibody 485 could not be obtained directly from the parent 157M virus in MDCK cells presumably because of the low frequency of occurrence of the required double mutant (~10 -9'13, Yewdell et al., 1979) . Selection of a resistant mutant occurred readily either in MDCK cells or in eggs if one of the two required substitutions was already present, as with isolate 157E or egg-adapted variants 5a, 5b or 2lb. Selection of a resistant mutant directly from parental 157M virus in eggs, apparently involved the initial selection of an egg-adapted virus.
Studies on the antigenic structure of influenza HA (Caton et al., 1982; Berton & Webster, 1985) , and on the surface proteins of other RNA viruses (Vandepol et al., 1986; Sherry et al., 1986; Coelingh et al., 1987) indicate that in general, a single amino acid substitution is sufficient for virus to escape neutralization. Sherry et aL (1986) suggested that some variants selected during a study of rhinovirus neutralization sites required two substitutions to achieve full resistance. In all other cases, there has been no demonstration that more than one substitution within a double mutant is necessary for resistance and the ease of isolation of reported double mutants suggests that only one substitution is required. One possibility for our observation is that the group C antibodies are not monoclonal. This is highly unlikely for the following reasons: isolation of eight MAbs, all of the same isotype (IgG class 2b), from two individual fusions by the agar technique, the stability of the cell lines; and the unaltered characteristics of the antibodies after 4 years of use. These factors argue for a homogeneous antibody preparation. In addition, the hybridoma cell line-secreting antibody 485 has recently been recloned and no change was observed in the HI profile of nine out of nine clones against the viruses listed in Table 4 . Thus we have described a unique class of MAbs against which variants must acquire two amino acid substitutions to escape neutralization.
We are indebted to Dr Clayton Naeve, Memphis, Tenn., U.S.A. for generating the computer printout of the HA 3D structure.
